David J. Sas

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

Sander F. Garrelfs, Yaacov Frishberg, Sally A. Hulton et al. · New England Journal of Medicine · 2021 · 469 citations · Full text

Increasing Incidence of Kidney Stones in Children Evaluated in the Emergency Department

David J. Sas, Thomas C. Hulsey, Ibrahim F. Shatat et al. · The Journal of Pediatrics · 2010 · 267 citations

Pediatric Emergency Medicine, Kidney Stones, Medicine +7

Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012

Gregory E. Tasian, Michelle Ross, Lihai Song et al. · Clinical Journal of the American Society of Nephrology · 2016 · 248 citations

Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children

David J. Sas, Daniella Magen, Wesley Hayes et al. · Genetics in Medicine · 2021 · 72 citations · Full text

Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2

Prince Singh, Jason K. Viehman, Ramila A. Mehta et al. · Nephrology Dialysis Transplantation · 2021 · 52 citations · Full text